Abstract
Purpose of Review
Spinal cord stimulation (SCS), based on the gate theory of nociception, has been shown to be effective in the management of chronic pain conditions. While early-generation technology offered many patients improvement in their pain and symptoms, limitations including paresthesia, dependence on mapping, decreased chronological efficacy, and inadequate coverage left many patients with persistent pain and overt therapeutic failure.
Recent Findings
New advances in neuromodulation technology circumvent many of these previous limitations and offer patients improved pain relief and quality of life.
Summary
In this review, an update on recent technological developments in the field of SCS and peripheral neuromodulation is presented with discussion on differentiating characteristics which may help guide applicability to individual patient needs.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Song JJ, Popescu A, Bell RL. Present and potential use of spinal cord stimulation to control chronic pain. Pain Physician. 2014;17:235–46.
Epstein LJ, Palmieri M. Managing chronic pain with spinal cord stimulation. Mt Sinai J Med. 2012;79:123–32.
Kapural L. Spinal cord stimulation for intractable chronic pain. Curr Pain Headache Rep. 2014;18:18–23.
North RB, Ewend MG, Lawton MT, Piantadosi S. Spinal cord stimulation for chronic, intractable pain: superiority of multi-channel devices. Pain. 1991;44:119–30.
Russo M, Van Buyten J-P. 10-kHz high-frequency SCS therapy: a clinical summary. Pain Med. Wiley-Blackwell. 2015;16:934–42.
Barolat G, Massaro F, He J, Zeme S, Ketcik B. Mapping of sensory responses to epidural stimulation of the intraspinal neural structures in man. J Neurosurg. 1993;78:233–9.
Dones I, Levi V. Spinal cord stimulation for neuropathic pain: current trends and future applications. Brain Sci. 2018;8.
•• Deer T, Slavin KV, Amirdelfan K, North RB, Burton AW, Yearwood TL, et al. Success Using Neuromodulation With BURST (SUNBURST) study: results from a prospective, randomized controlled trial using a novel burst waveform. Neuromodulation. 2018;21:56–66 Results from the prospective RCT SUNBURST study on neuromodulation with burst waveform technology.
Shurrab M, Kaoutskaia A, Baranchuk A, Lau C, Singarajah T, Lashevsky I, et al. Are there increased periprocedural complications with the MRI-conditional Medtronic Revo SureScan Pacing System?: A meta-analysis. Neth Heart J. 2018;26:233–9.
De Carolis G, Paroli M, Tollapi L, Doust MW, Burgher AH, Yu C, et al. Paresthesia-independence: an assessment of technical factors related to 10 kHz paresthesia-free spinal cord stimulation. Pain Physician. 2017;20:331–41.
Medtronic. Spinal cord stimulation systems - Intellis platform [Internet]. Hist. | Medtronic. 2018.
Williamson BD, Gohn DC, Ramza BM, Singh B, Zhong Y, Li S, et al. Real-world evaluation of magnetic resonance imaging in patients with a magnetic resonance imaging conditional pacemaker system: results of 4-year prospective follow-up in 2,629 patients. JACC Clin Electrophysiol. 2017;3:1231–9.
Schultz DM, Webster L, Kosek P, Dar U, Tan Y, Sun M. Sensor-driven position-adaptive spinal cord stimulation for chronic pain. Pain Physician. 2012;15:1–12.
Goudman L, Smet I, Mariën P, De Jaeger M, De Groote S, Huysmans E, et al. Is the self-reporting of failed back surgery syndrome patients treated with spinal cord stimulation in line with objective measurements? Neuromodulation. 2018;21:93–100.
•• Kapural L, Yu C, Doust MW, Gliner BE, Vallejo R, Sitzman BT, et al. Comparison of 10-kHz high-frequency and traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain. Neurosurgery. 2016;79:667–77 A RCT study with a 24-month follow-up comparing results of HF-10 therapy to traditional low-frequency SCS.
Nevro Corp. Procedure benefits [Internet]. Nevro - about us - who we are. 2018.
Kapural L, Yu C, Doust MW, Gliner BE, Vallejo R, Sitzman BT, et al. Novel 10-kHz high-frequency therapy (HF10 therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain: the SENZA-RCT randomized controlled trial. Anesthesiology. 2015;123:851–60.
Liem L. Stimulation of the dorsal root ganglion. Prog Neurol Surg. 2015;213–224.
Kent AR, Min X, Hogan QH, Kramer JM. Mechanisms of dorsal root ganglion stimulation in pain suppression: a computational modeling analysis. Neuromodulation. 2018;21:234–46.
Billet B, Hanssens K, De Coster O, Nagels W, Weiner RL, Wynendaele R, et al. Wireless high-frequency dorsal root ganglion stimulation for chronic low back pain: a pilot study. Acta Anaesthesiol Scand. 2018;62:1133–8.
Eldabe S, Espinet A, Wahlstedt A, Kang P, Liem L, Patel NK, et al. Retrospective case series on the treatment of painful diabetic peripheral neuropathy with dorsal root ganglion stimulation. Neuromodulation. 2018;21:787–92.
Morgalla MH, Bolat A, Fortunato M, Lepski G, Chander BS. Dorsal root ganglion stimulation used for the treatment of chronic neuropathic pain in the groin: a single-center study with long-term prospective results in 34 cases. Neuromodulation. 2017;20:753–60.
Mol FMU, Roumen RM, Scheltinga MR. Comparing the efficacy of targeted spinal cord stimulation (SCS) of the dorsal root ganglion with conventional medical management (CMM) in patients with chronic post-surgical inguinal pain: the SMASHING trial. BMC Surg. 2018;18:18.
Vuka I, Vučić K, Repić T, Ferhatović Hamzić L, Sapunar D, Puljak L. Electrical stimulation of dorsal root ganglion in the context of pain: a systematic review of in vitro and in vivo animal model studies. Neuromodulation. 2018;21:213–24.
Xu J, Liu A, Cheng J. New advancements in spinal cord stimulation for chronic pain management. Curr Opin Anaesthesiol. 2017;30:710–7.
De Ridder D, Plazier M, Kamerling N, Menovsky T, Vanneste S. Burst spinal cord stimulation for limb and back pain. World Neurosurg. 2013;80:642–649.e1.
Thomson S. Spinal cord stimulation for neuropathic pain. Int Neuromodulation Soc. 2017
Weiner RL, Yeung A, Montes Garcia C, Tyler Perryman L, Speck B. Treatment of FBSS low back pain with a novel percutaneous DRG wireless stimulator: pilot and feasibility study. Pain Med. 2016;17:1911–6.
Perryman LT. Wireless neuromodulation in the management of chronic refractory FBSS back pain: preliminary prospective experience with different stimulation targets and waveforms. Anesth Perioper Manag J. 2018;2:1–4.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Omar Viswanath, Ivan Urits, Emily Bouley, Jacquelin M. Peck, and William Thompson declares no conflict of interest. Dr. Kaye discloses that he is on the Speakers Bureau for Depomed, Inc. and Merck.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Other Pain
Rights and permissions
About this article
Cite this article
Viswanath, O., Urits, I., Bouley, E. et al. Evolving Spinal Cord Stimulation Technologies and Clinical Implications in Chronic Pain Management. Curr Pain Headache Rep 23, 39 (2019). https://doi.org/10.1007/s11916-019-0778-9
Published:
DOI: https://doi.org/10.1007/s11916-019-0778-9